You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 11, November 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 28TH SCIENTIFIC MEETING OF THE INTERNATIONAL CARDIOVASCULAR SOCIETY, CHICAGO, JUNE 27-28, 1980
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Why Operate on Carotid Fibromuscular Dysplasia?

David J. Effeney, MB, BS, FRACS; William K. Ehrenfeld, MD; Ronald J. Stoney, MD; Edwin J. Wylie, MD

Arch Surg. 1980;115(11):1261-1265.


Abstract

• Serious antecedent neurologic events occurred in 86 patients operated on for fibromuscular dysplasia (FMD). We applied the following criteria to the assessment of outcome: (1) the lesion should be surgically accessible; (2) the operation should be performed with minimal risk; (3) the operative repair is durable; and (4) benefits of repair are long lasting. Intraluminal dilation fulfills the first criterion: 118 dilations have been performed in 79 patients, with no deaths, three postoperative strokes that recovered completely, and eight single episodes of transient ischemia or amaurosis. The repair was durable, there being one late closure of a dilated artery. There were two subarachnoid hemorrhages, two strokes, and two patients had recurrence of symptoms during the follow-up period. Intraluminal dilation should be offered to patients with symptomatic FMD. A registry of patients with asymptomatic FMD should be established to study its natural history.

(Arch Surg 115:1261-1265, 1980)



Author Affiliations

From the Department of Surgery, University of California Medical Center (Drs Ehrenfeld, Stoney, and Wylie), and Surgical Service, Veterans Administration Medical Center (Dr Effeney), San Francisco.


Footnotes

Accepted for publication July 21, 1980.

Read before the 28th scientific meeting of the International Cardiovascular Society, Chicago, June 27, 1980.

Reprint requests to Veterans Administration Medical Center, 4150 Clement St, San Francisco, CA 94121 (Dr Effeney).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intracranial and Extracranial Aspects of Carotid Fibromuscular Dysplasia
Reisner and Barrow
PERSPECT VASC SURG ENDOVASC THER 1992;5:31-57.
 

Expert Commentary
Clagett and Bowers
PERSPECT VASC SURG ENDOVASC THER 1992;5:58-59.
 

Transluminal Dilatation of the Internal Carotid Artery in Fibromuscular Dysplasia A Case History
van den Hoven et al.
ANGIOLOGY 1988;39:272-275.
ABSTRACT  

Fibromuscular Dysplasia of the Right Subclavian Artery
McCready et al.
Arch Surg 1982;117:1243-1245.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.